IGC Pharma Inc (IGC)

May 23, 2026

IGC Pharma Q1 2026 Earnings: Narrower Loss Beats Estimates; Shares Edge LowerTrading Community - Newser

May 23, 2026

May 22, 2026

IGC Stock Price, Quote & Chart | IGC PHARMA INC (NYSEARCA:IGC) - ChartMill

May 22, 2026

May 21, 2026

IGC Pharma earnings beat, revenue topped estimates By Investing.com - Investing.com Australia

May 21, 2026

May 20, 2026

IGC Pharma (IGC) Q1 2026 Earnings: $-0.02 EPS Surges Past $-0.02 EstimatesEstimate Revision Count - Newser

May 20, 2026

May 20, 2026

IGC Pharma (IGC) Delivers Q1 2026 Beat — EPS $-0.02 vs $-0.02 ExpectedForward EPS Estimate - Newser

May 20, 2026

May 20, 2026

IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment - BioSpace

May 20, 2026

May 19, 2026

Drug trial for Alzheimer’s agitation reaches 80% enrollment at IGC Pharma - Stock Titan

May 19, 2026

May 18, 2026

IGC Pharma (IGC) Q1 2026 Earnings Surprise: EPS $-0.02, Up SignificantPopular Trader Picks - Newser

May 18, 2026

May 16, 2026

New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas, Virtuix Holdings (NASDAQ:VTIX), and Medi - Voice of Alexandria

May 16, 2026

May 16, 2026

IGC Pharma to Present Tau-PET Biomarker Research at 2026 Global Tau Conference - Black Hills Pioneer

May 16, 2026

May 15, 2026

IGC Pharma, Inc. Common Stock (NY: IGC - The Chronicle-Journal

May 15, 2026

May 15, 2026

IGC Pharma (NYSE: IGC) deepens Alzheimer’s R&D amid tight cash and new loans - Stock Titan

May 15, 2026

May 15, 2026

IGC Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 15, 2026

May 15, 2026

IGC Unveils Tau-PET Biomarker Study for Alzheimer's at Global Ta - GuruFocus

May 15, 2026

May 15, 2026

IGC Pharma Presents Tau-PET Alzheimer’s Research - ACCESS Newswire

May 15, 2026

May 14, 2026

Decoding Tau Heterogeneity: IGC Pharma Presents Novel Biomarker Research at the 2026 Global Tau Conference - marketscreener.com

May 14, 2026

May 14, 2026

TradingKey - TradingKey

May 14, 2026

May 13, 2026

New Strong Buy Stocks for Oct. 24: IGC, ASM and More - MSN

May 13, 2026

May 09, 2026

New to The Street Broadcasts Show #752 on Bloomberg Television Featuring Graphene Manufacturing Group (OTCQX:GMGRF), T-REX Acquisition Corp (NASDAQ:TRXA), KITON, and Roadzen (NASDAQ:RDZN) - ChartMill

May 09, 2026

May 08, 2026

The key trends fueling IGC Pharma (IGC) growth potential (Institutional Selling) 2026-05-08Wall Street Picks - Newser

May 08, 2026

May 07, 2026

IGC Technical Analysis & ETF Price Forecast - Intellectia AI

May 07, 2026

May 01, 2026

IGC Should I Buy - Intellectia AI

May 01, 2026

Apr 30, 2026

MSN Money - MSN

Apr 30, 2026

Apr 30, 2026

Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification - marketscreener.com

Apr 30, 2026

Apr 29, 2026

Cannabinoid Clinical Trials See Significant Growth for New… - Hemp Gazette

Apr 29, 2026

Apr 29, 2026

Cannabinoid Clinical Trials Gain Momentum: 50+ Companies Le… - Hemp Gazette

Apr 29, 2026

Apr 29, 2026

IGC Pharma Advances Caregiver Engagement as Phase 2 CALMA Trial Advances Final Enrollment Phase - BioSpace

Apr 29, 2026

Apr 28, 2026

As Alzheimer’s trial nears completion, IGC turns to caregivers - Stock Titan

Apr 28, 2026

Apr 25, 2026

New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global - Scott Coop

Apr 25, 2026

Apr 25, 2026

Analysts Are Bullish on Top Healthcare Stocks: IGC Pharma (IGC), 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail

Apr 25, 2026

Apr 24, 2026

IGC Pharma Adds Kerwin Medical Center in Dallas to Phase 2 CALMA Trial as Enrollment Advances Toward Completion - itemonline.com

Apr 24, 2026

Apr 24, 2026

IGC Pharma Secures Psilocybin Research Authorization, Expanding Focus on Neuropsychiatric Symptoms in Dementia - Times Argus

Apr 24, 2026

Apr 23, 2026

IGC Pharma Inc. (IGC) posts narrower than expected Q1 2026 loss, reports 5.5 percent year over year revenue decline.Crowd Sentiment Stocks - UBND thành phố Hải Phòng

Apr 23, 2026

Apr 23, 2026

IGC Pharma (IGC) Stock: Why Competitive Advantage (Slight Downtick) 2026-04-22Reversal Picks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 23, 2026

Apr 22, 2026

ETFs Investing in IGC Pharma, Inc. Stocks - TradingView

Apr 22, 2026

Apr 22, 2026

IGC Pharma Adds Kerwin Medical Center in Dallas to Phase 2 CALMA - GuruFocus

Apr 22, 2026

Apr 22, 2026

IGC Expands Clinical Trials with New Site in Dallas - GuruFocus

Apr 22, 2026

Apr 21, 2026

IGC Pharma Secures New Promissory Note Financing Agreements - The Globe and Mail

Apr 21, 2026

Apr 20, 2026

IGC Pharma (IGC) Stock: Risk vs Reward (Underperforming) 2026-04-20Wall Street Picks - Xã Châu Thành

Apr 20, 2026

Apr 20, 2026

IGC Pharma Adds $514,000 in 12% Notes From FirstFire and Vanquish Funding - TradingView

Apr 20, 2026